Avadel Pharmaceuticals (AVDL) Q2 2023 Earnings

9AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-0.66
-0.44
-0.22
0

Details

Expected EPS
-0.38
Actual EPS
-0.66
Surprise EPS
-0.28
Surprise Percent
+73.68%

Description

Avadel Pharmaceuticals (AVDL) has reported earnings of -0.66 per share for Q2 2023.

0 Comments

Share your thoughts